JamesFVanderMD
Ophthalmology • Plymouth Meeting, PARetinal Disease
Professor of Ophthalmology, Thomas Jefferson University
Dr. Vander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4060 Butler Pike
Ste 200
Plymouth Meeting, PA 19462Phone+1 800-331-6634Fax+1 267-420-1360
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1988 - 1990
University of Michigan Health SystemResidency, Ophthalmology, 1985 - 1988
Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1984 - 1985
University of Michigan Medical SchoolClass of 1984
Certifications & Licensure
NJ State Medical License 1990 - 2025
PA State Medical License 1988 - 2024- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- Philadelphia Magazine Castle Connolly, 2006-2014
- Super Doctor SuperDoctors.com
- Join now to see all
Publications & Presentations
PubMed
- Macular chorioretinal scar a as rare complication of serous retinal detachment in retinopathy of prematurity.Pauline Marie Dmitriev, Yutong Li, James F Vander, Barry N Wasserman
BMJ Case Reports. 2024-11-14 - Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.Asad F Durrani, Bita Momenaei, Viren Soni, Matthew Tennant, Jason Hsu
Journal of Ocular Pharmacology and Therapeutics. 2024-11-01 - Outcomes in eyes with retained lens fragments undergoing pars plana lensectomy and scleral-fixated intraocular lens insertion.Asad F Durrani, Bita Momenaei, Jonathan L Martin, Taku Wakabayashi, Saif A Hamdan
Retina. 2024-10-23
Journal Articles
- Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular DegenerationSamir N Patel, Jeremy D Wolfe, Sunir J Garg, Marc J Spirn, James F Vander, JAMA Ophthalmology
- Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular DegenerationSamir N Patel, Jeremy D Wolfe, Sunir J Garg, Marc J Spirn, James F Vander, JAMA Ophthalmology
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
